GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also ...

Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...

Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...

F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an ...

UK drugmaker GSK is struggling to convince the market that ... particularly in speciality medicines and in areas like oncology.” The drugmaker does not have one potential mega blockbuster ...

The pharmaceutical industry faces significantly longer lead times than other industries, and time delays can seriously impact the health outcomes of countless individuals. Recognizing the potential ...

The activity of TC1 was discovered by chance by GSK researchers in Tres Cantos, Spain, who were carrying out research on new antimalarial ... 10 years on R&D in this area. It was responsible ...

In its annual report published on Thursday, GSK said: “Going forward, we will make changes in several areas related to inclusion ... on industry-leading research and development progress and ...